Patterns of pelvic radiotherapy in patients with stage II/III rectal cancer

Simple item page
dc.contributor.authorFitzgerald, Timothy L.
dc.contributor.authorZervos, Emmanuel
dc.contributor.authorWong, Jan H.
dc.date.accessioned2020-03-31T03:31:20Z
dc.date.available2020-03-31T03:31:20Z
dc.date.issued2013-10-02
dc.description.abstractHigh-level evidence supports adjuvant radiotherapy for rectal cancer. We examined the influence of sociodemographic factors on patterns of adjuvant radiotherapy for resected Stage II/III rectal cancer. Methods. Patients undergoing surgical resection for stage II/III rectal cancer were identified in SEER registry. Results. A total of 21,683 patients were identified. Majority of patients were male (58.8%), white (83%), and with stage III (54.9%) and received radiotherapy (66%). On univariate analysis, male gender, stage III, younger age, year of diagnosis, and higher socioeconomic status (SES) were associated with radiotherapy. Radiotherapy was delivered in 84.4% of patients < 50; however, only 32.8% of those are > 80 years. Logistic regression demonstrated a significant increase in the use of radiotherapy in younger patients who are < 50 (OR, 10.3), with stage III (OR, 1.21), males (OR, 1.18), and with higher SES. Conclusions. There is a failure to conform to standard adjuvant radiotherapy in one-third of patients, and this is associated with older age, stage II, area-level of socioeconomic deprivation, and female sex.en_US
dc.identifier.doi10.1155/2013/408460
dc.identifier.urihttp://hdl.handle.net/10342/7724
dc.titlePatterns of pelvic radiotherapy in patients with stage II/III rectal canceren_US
dc.typeArticleen_US
ecu.journal.issue408460en_US
ecu.journal.nameJournal of Cancer Epidemiologyen_US
ecu.journal.pages1-6en_US
ecu.journal.volume2013en_US

Files

Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
JCE2013-408460.pdf
Size:
485.56 KB
Format:
Adobe Portable Document Format
Description:
Download

Collections

Open Access